Identifying barriers to the availability and use of magnesium sulphate injection in resource poor countries: A case study in Zambia

BMC Health Services Research

Volumn 10, Issue , 2010, Pages

  Ridge, Anna L ^a   Bero, Lisa A ^b   Hill, Suzanne R ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAGNESIUM SULFATE; UTERUS SPASMOLYTIC AGENT;

ARTICLE; CLINICAL COMPETENCE; DEVICES; DRUG INDUSTRY; DRUG LEGISLATION; ECLAMPSIA; ECONOMICS; EDUCATION; FEMALE; GOVERNMENT REGULATION; HEALTH CARE DELIVERY; HEALTH CARE DISPARITY; HEALTH CARE FACILITY; HEALTH CARE PERSONNEL; HEALTH SERVICES RESEARCH; HUMAN; IN SERVICE TRAINING; MIDWIFE; OBSTETRICS; PHYSICIAN; POVERTY; PRACTICE GUIDELINE; PREECLAMPSIA; PREGNANCY; PSYCHOLOGICAL ASPECT; PUBLIC HEALTH; PUBLIC HEALTH SERVICE; STANDARD; STATISTICS; ZAMBIA;

CLINICAL COMPETENCE; DRUG INDUSTRY; ECLAMPSIA; EQUIPMENT AND SUPPLIES; FEMALE; GOVERNMENT REGULATION; HEALTH FACILITIES; HEALTH PERSONNEL; HEALTH SERVICES ACCESSIBILITY; HEALTHCARE DISPARITIES; HUMANS; INSERVICE TRAINING; LEGISLATION, DRUG; MAGNESIUM SULFATE; MIDWIFERY; NATIONAL HEALTH PROGRAMS; OBSTETRICS; ORGANIZATIONAL CASE STUDIES; PHYSICIANS; POVERTY; PRACTICE GUIDELINES AS TOPIC; PRE-ECLAMPSIA; PREGNANCY; PUBLIC HEALTH PRACTICE; TOCOLYTIC AGENTS; ZAMBIA;

EID: 78650158576     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-10-340     Document Type: Article

References (22)

1. World Health Organization, The World Health Report 2005: Make every mother and child count Geneva: World Health Organization 2005 - - Either first page or author must be supplied.
2. Global burden of hypertensive disorders of pregnancy in the year 2000. C Dolea C AbouZahr, Global Burden of Diseases 2000 Working Paper Geneva: World Health Organization 2003
3. Magnesium sulphate versus lytic cocktail for eclampsia. L Duley AM Gulmezoglu, Cochrane Database of Systematic Reviews 2000 3 D002960
4. Magnesium sulphate versus diazepam for eclampsia. L Duley DJ Henderson-Smart, Cochrane Database of Systematic Reviews 2003 4 D000127
5. Magnesium sulphate versus phenytoin for eclampsia. L Duley DJ Henderson-Smart, Cochrane Database of Systematic Reviews 2003 4 D000128
6. Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. L Duley AM Gülmezoglu DJ Henderson-Smart, Cochrane Database of Systematic Reviews 2003 4 D000125
7. WHO Model List of Essential Medicines. http://www.who.int/medicines/ publications/essentialmedicines/en/index.html - - Either ISSN or Journal title must be supplied.
8. System and market failures: the unavailability of magnesium sulphate for the treatment of eclampsia and pre-eclampsia in Mozambique and Zimbabwe. E Sevene S Lewin A Mariano G Woelk AD Oxman S Matinhure J Cliff B Fernandes K Daniels, BMJ 2005 331 765 769 10.1136/bmj.331.7519.765 16195297
9. Translating research into policy in developing countries: a case study of magnesium sulphate for pre-eclampsia. M Aaserud S Lewin S Innvar EJ Paulsen AT Dahlgren M Trommald L Duley M Zwarenstein A Oxman, BMC Health Services Research 2005 5 68 10.1186/1472-6963-5-68 16262902
10. Identifying barriers and tailoring interventions to improve the management of urinary tract infections and sore throat: a pragmatic study using qualitative methods. S Flottorp A Oxman, BMC Health Services Research 2003 3 3 10.1186/1472-6963-3-3 12622873
11. Zambia Demographic and Health Survey 2001-2002. http://www.measuredhs. com/pubs/pdf/FR136/00FrontMatter.pdf - - Either ISSN or Journal title must be supplied.
12. Zambia: family planning quantitative and qualitative logistic system assessment. A Disha M Bwembya E Collins D Papworth E Ronnow, USAID/DELIVER PROJECT, Task Order 1.USA: Arlington, Virginia 2008 19125713
13. Improving patient care. The implementation of change in clinical practice. R Grol M Wensing M Eccles, United Kingdom: Elsevier Limited 2005
14. Perceptions of patients and health care professionals about factors contributing to medication errors and potential areas for improvement. N Hartnell NJ MacKinnon EJM Jones R Genge MDM Nestel, Canadian Journal of Hospital Pharmacy 2006 59 4 177 83
15. World Health Organization, Pregnancy, childbirth, postpartum and newborn care: a guide for essential practice Geneva: World Health Organization 2 2006 - - Either first page or author must be supplied.
16. Managing complications in pregnancy and childbirth: a guide for midwives and doctors. World Health Organization, Geneva: World Health Organization 2 2007
17. World Health Organization, The Rational Use of Drugs. Report of the Conference of Experts 1985 Geneva: WHO 1987 - - Either first page or author must be supplied.
18. Evidence-based reproductive health care in Cameroon: population-based study of awareness, use and barriers. ATN Tita BJ Selwyn DK Waller AS Kapadia S Dongmo, Bulletin of the World Health Organization 2005 83 895 903 16462981
19. Management Sciences for Health in collaboration with the World Health Organization, Managing Drug Supply USA: Kumarian Press 1997 - - Either first page or author must be supplied.
20. LJ Frost MR Reich, Access: How do good health technologies get to poor people in poor countries? USA: Harvard University Press 2008
21. Translating research into maternal health care policy: a qualitative case study of the use of evidence in policies for the treatment of eclampsia and pre-eclampsia in South Africa. K Daniels S Lewin the Practihc Policy Group (ppg), Health Research Policy and Systems 2008 6 12 10.1186/1478-4505-6-12 19091083
22. Factors influencing the utilization of research findings by health policy-makers in a developing country: the selection of Mali's essential medicines. AM Albert A Fretheim D Maga, Health Research Policy and Systems 2007 5 2 10.1186/1478-4505-5-2 17338810